These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 21618474)

  • 21. Engineered single chain antibody fragments for radioimmunotherapy.
    Huhalov A; Chester KA
    Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):279-88. PubMed ID: 15640791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library.
    Vaughan TJ; Williams AJ; Pritchard K; Osbourn JK; Pope AR; Earnshaw JC; McCafferty J; Hodits RA; Wilton J; Johnson KS
    Nat Biotechnol; 1996 Mar; 14(3):309-14. PubMed ID: 9630891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody therapeutics, antibody engineering, and the merits of protein stability.
    Demarest SJ; Glaser SM
    Curr Opin Drug Discov Devel; 2008 Sep; 11(5):675-87. PubMed ID: 18729019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multivalency: the hallmark of antibodies used for optimization of tumor targeting by design.
    Deyev SM; Lebedenko EN
    Bioessays; 2008 Sep; 30(9):904-18. PubMed ID: 18693269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Humanization of an anti-lymphocyte function-associated antigen (LFA)-1 monoclonal antibody and reengineering of the humanized antibody for binding to rhesus LFA-1.
    Werther WA; Gonzalez TN; O'Connor SJ; McCabe S; Chan B; Hotaling T; Champe M; Fox JA; Jardieu PM; Berman PW; Presta LG
    J Immunol; 1996 Dec; 157(11):4986-95. PubMed ID: 8943405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein aggregation kinetics during Protein A chromatography. Case study for an Fc fusion protein.
    Shukla AA; Gupta P; Han X
    J Chromatogr A; 2007 Nov; 1171(1-2):22-8. PubMed ID: 17920607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimal construction of non-immune scFv phage display libraries from mouse bone marrow and spleen established to select specific scFvs efficiently binding to antigen.
    Okamoto T; Mukai Y; Yoshioka Y; Shibata H; Kawamura M; Yamamoto Y; Nakagawa S; Kamada H; Hayakawa T; Mayumi T; Tsutsumi Y
    Biochem Biophys Res Commun; 2004 Oct; 323(2):583-91. PubMed ID: 15369791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integration of PEGylation and refolding for renaturation of recombinant proteins from insoluble aggregates produced in bacteria--application to a single-chain Fv fragment.
    Kumagai I; Asano R; Nakanishi T; Hashikami K; Tanaka S; Badran A; Sanada H; Umetsu M
    J Biosci Bioeng; 2010 May; 109(5):447-52. PubMed ID: 20347766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and prevention of antibody disulfide bond reduction during cell culture manufacturing.
    Trexler-Schmidt M; Sargis S; Chiu J; Sze-Khoo S; Mun M; Kao YH; Laird MW
    Biotechnol Bioeng; 2010 Jun; 106(3):452-61. PubMed ID: 20178122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Feasibility of polyelectrolyte-driven Fab fragment separation.
    Capito F; Kolmar H; Edelmann B; Skudas R
    Biotechnol J; 2014 May; 9(5):698-701. PubMed ID: 24659538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibodies and genetically engineered related molecules: production and purification.
    Roque AC; Lowe CR; Taipa MA
    Biotechnol Prog; 2004; 20(3):639-54. PubMed ID: 15176864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Guest editor's introduction--antibody engineering.
    Rüker F
    Arch Biochem Biophys; 2012 Oct; 526(2):85-6. PubMed ID: 22944043
    [No Abstract]   [Full Text] [Related]  

  • 33. Process optimization and protein engineering mitigated manufacturing challenges of a monoclonal antibody with liquid-liquid phase separation issue by disrupting inter-molecule electrostatic interactions.
    Du Q; Damschroder M; Pabst TM; Hunter AK; Wang WK; Luo H
    MAbs; 2019; 11(4):789-802. PubMed ID: 30913985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A tale of two specificities: bispecific antibodies for therapeutic and diagnostic applications.
    Byrne H; Conroy PJ; Whisstock JC; O'Kennedy RJ
    Trends Biotechnol; 2013 Nov; 31(11):621-32. PubMed ID: 24094861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction and Reduction of the Aggregation of Monoclonal Antibodies.
    van der Kant R; Karow-Zwick AR; Van Durme J; Blech M; Gallardo R; Seeliger D; Aßfalg K; Baatsen P; Compernolle G; Gils A; Studts JM; Schulz P; Garidel P; Schymkowitz J; Rousseau F
    J Mol Biol; 2017 Apr; 429(8):1244-1261. PubMed ID: 28322916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single framework recombinant antibody fragments designed for protein chip applications.
    Steinhauer C; Wingren C; Hager AC; Borrebaeck CA
    Biotechniques; 2002 Dec; Suppl():38-45. PubMed ID: 12514928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formulation and manufacturability of biologics.
    Shire SJ
    Curr Opin Biotechnol; 2009 Dec; 20(6):708-14. PubMed ID: 19880308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purification of proteins from baculovirus-infected insect cells.
    O'Shaughnessy L; Doyle S
    Methods Mol Biol; 2011; 681():295-309. PubMed ID: 20978972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multi-dimensional fractionation and characterization of crude protein mixtures: toward establishment of a database of protein purification process development parameters.
    Nfor BK; Ahamed T; Pinkse MW; van der Wielen LA; Verhaert PD; van Dedem GW; Eppink MH; van de Sandt EJ; Ottens M
    Biotechnol Bioeng; 2012 Dec; 109(12):3070-83. PubMed ID: 22688729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resolving self-association of a therapeutic antibody by formulation optimization and molecular approaches.
    Casaz P; Boucher E; Wollacott R; Pierce BG; Rivera R; Sedic M; Ozturk S; Thomas WD; Wang Y
    MAbs; 2014; 6(6):1533-9. PubMed ID: 25484044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.